ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat
瑞思迈瑞思迈(US:RMD) Reuters·2026-08-08 00:01

公司业绩与市场反应 - ResMed股价在周五早盘下跌约6% [1] - 公司预测2027财年营收低于华尔街预期 [1] - 营收预期受暂停呼吸机销售及成本影响 [1]

ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat - Reportify